Current therapy of polyarticular forms of juvenile idiopathic arthritis

被引：0

作者：

Hospach, A. ^{[1
]}

Ruehlmann, J. M.

Weller-Heinemann, F. ^{[2
]}

机构：

[1] Olga Hosp, Klinikum Stuttgart, Zentrum Padiatr Rheumatol, Kriegsbergstr 62, D-70174 Stuttgart, Germany

[2] Gesundheit Nord Klin Verbund Bremen, Prof Hess Kinderklin, Zentrum Kinderheilkunde & Jugendmed, Klinikum Bremen Mitte, Bremen, Germany

来源：

ZEITSCHRIFT FUR RHEUMATOLOGIE | 2016年 / 75卷 / 03期

关键词：

Juvenile idiopathic arthritis; Polyarthritis; Disease modifying antirheumatic drugs; Biologics; Therapy; CERVICAL-SPINE INVOLVEMENT; DOUBLE-BLIND; RHEUMATOID-ARTHRITIS; DISEASE-ACTIVITY; PEDIATRIC RHEUMATOLOGY; CHILDHOOD ARTHRITIS; FOLLOW-UP; METHOTREXATE; CHILDREN; ETANERCEPT;

D O I：

10.1007/s00393-016-0063-9

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Juvenile idiopathic arthritis (JIA) is the most common rheumatic disease in infancy and childhood. Approximately 20 % of patients with JIA suffer from the polyarticular form of the disease, which causes a substantial disease burden and long-term sequelae. Therapeutic approaches have used steroids and conventional disease modifying antirheumatic drugs (DMARD) but over the last decade new drugs have become available for the treatment of JIA, in particular biologic DMARD. This article summarizes the current therapy options for polyarticular JIA.

引用

页码：284 / 291

页数：8

共 50 条

[21] Polyarticular juvenile idiopathic arthritis versus adult onset rheumatoid arthritis
Ozdogan, H
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 10 - 10
[22] Polyarticular juvenile idiopathic arthritis and rheumatoid arthritis Common features and differences
Haas, Johannes-Peter
Weimann, Vincent
Feist, Eugen
[J]. ZEITSCHRIFT FUR RHEUMATOLOGIE, 2022, 81 (01): : 4 - 13
[23] Aktuelle Therapie der polyartikulären Verlaufsform der juvenilen idiopathischen ArthritisCurrent therapy of polyarticular forms of juvenile idiopathic arthritis
A. Hospach
J. M. Rühlmann
F. Weller-Heinemann
[J]. rheuma plus, 2017, 16 (2) : 50 - 58
[24] Pharmacokinetics and pharmacodynamics of long-term tocilizumab therapy in polyarticular juvenile idiopathic arthritis
Fettner, Scott
Lu, Peng
Hsu, Joy
Keane, Caroline
Wang, Jianmei
Ruperto, Nicolino
De Benedetti, Fabrizio
Brunner, Hermine
[J]. PHARMACOTHERAPY, 2013, 33 (10): : E234 - E234
[25] Utilization of Biologic Treatments in Oligoarticular and Polyarticular Juvenile Idiopathic Arthritis
Basodan, Daniah
Andersen, Kathleen M.
Li, Xintong
Curtis, Jeff Rey
Alexander, G. Caleb
[J]. ARTHRITIS & RHEUMATOLOGY, 2019, 71
[26] Elucidating Pain Mechanisms in Polyarticular Juvenile Idiopathic Arthritis Patients
Upadhyay, Jaymin
Sibai, Diana
Labadie, Robert
Lernme, Jordan
Sieberg, Christine
Ecklund, Kirsten
Borsook, David
Sundel, Robert
[J]. ARTHRITIS & RHEUMATOLOGY, 2019, 71
[27] Oral or Parenteral Methotrexate for the Treatment of Polyarticular Juvenile Idiopathic Arthritis
Bakry, Reima
Klein, Med A.
Horneff, Gerd
[J]. EUROPEAN JOURNAL OF RHEUMATOLOGY, 2022, 9 (04) : 197 - 205
[28] Successful treatment of refractory polyarticular juvenile idiopathic arthritis with rituximab
Kuek, A.
Hazleman, B. L.
Gaston, J. H.
Ostor, A. J. K.
[J]. RHEUMATOLOGY, 2006, 45 (11) : 1448 - 1449
[29] Intestinal Microbiome In Polyarticular Juvenile Idiopathic Arthritis: A PILOT Study
Muller, Petra C. E. Hissink
Budding, A. E.
Allaart, Cornelia F.
Brinkman, Danielle M. C.
Kuijpers, Taco W.
Westedt, Michiel
van den Berg, J. Merlijn
Van Suijlekom-Smit, Lisette W. A.
Van Rossum, Marion A. J.
de Meij, Tim G. J.
Ten Cate, Rebecca
[J]. ARTHRITIS AND RHEUMATISM, 2013, 65 : S934 - S934
[30] T Helper Cell Differentiation in Polyarticular Juvenile Idiopathic Arthritis
Patrick, Anna
Esmond, Tashawna
Flaherty, David
Graham, Thomas Brent
Thompson, Susan
Aune, Thomas
[J]. ARTHRITIS & RHEUMATOLOGY, 2020, 72 : 261 - 262

← 1 2 3 4 5 →